#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	17086	16S	1529	1529	100.0	16S.l15.c30.ctg.1	2372	878.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1606	1606	C	1094	C,T	1093,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28820	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4177	861.7	0	.	n	.	0	T695C	SNP	695	695	T	1299	1299	C	1073	C,T,G,A	1070,1,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28820	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4177	861.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1941	1941	A	1190	A	1190	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28820	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4177	861.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2575	2575	C	1041	C,T	1040,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28820	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4177	861.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2649	2649	A	943	A,C	942,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28820	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4177	861.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3201	3201	C	992	C	992	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	2514	folP	852	852	100.0	folP.l15.c4.ctg.1	2036	153.9	1	SNP	p	R228S	1	.	.	682	684	AGC	1193	1195	AGC	261;259;257	A;G;C	261;259;257	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5488	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3915	175.0	1	SNP	p	S91F	0	.	.	271	273	TCC	849	851	TCC	196;193;194	T,A;C;C,A	195,1;193;193,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5488	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3915	175.0	1	SNP	p	D95N	0	.	.	283	285	GAC	861	863	GAC	190;190;193	G;A,T;C,T	190;189,1;192,1	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5488	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3915	175.0	1	SNP	p	D95G	0	.	.	283	285	GAC	861	863	GAC	190;190;193	G;A,T;C,T	190;189,1;192,1	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2248	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1902	147.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	740	742	ACC	255;253;254	A,G;C;C	254,1;253;254	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2248	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1902	147.6	0	.	p	.	0	R44H	NONSYN	130	132	CGC	755	757	CAC	255;257;258	C;A,G;C,G	255;256,1;257,1	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2248	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1902	147.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	938	940	CAC	301;301;301	C;A,T;C,G	301;300,1;300,1	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	539	2248	mtrR	633	633	99.21	mtrR.l15.c4.ctg.1	1902	147.6	1	SNP	p	G45D	0	.	.	133	135	GGC	758	760	GGC	260;262;263	G;G;C	260;262;263	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1296	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1394	115.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5924	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3618	204.5	1	SNP	p	D86N	0	.	.	256	258	GAC	840	842	GAC	238;238;236	G,C;A,G;C	237,1;236,2;236	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5924	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3618	204.5	1	SNP	p	S87W	0	.	.	259	261	AGT	843	845	AGT	236;235;236	A,T,C;G;T,G	234,1,1;235;235,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5924	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3618	204.5	1	SNP	p	S87R	0	.	.	259	261	AGT	843	845	AGT	236;235;236	A,T,C;G;T,G	234,1,1;235;235,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5924	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3618	204.5	1	SNP	p	S87I	0	.	.	259	261	AGT	843	845	AGT	236;235;236	A,T,C;G;T,G	234,1,1;235;235,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	5924	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3618	204.5	1	SNP	p	S88P	0	.	.	262	264	TCC	846	848	TCC	237;239;241	T;C,T;C	237;238,1;241	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4968	parE	1986	1986	100.0	parE.l6.c17.ctg.1	3252	190.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1869	1871	GGC	270;271;269	G;G;C	270;271;269	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2887	191.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1526	1528	GCA	257;258;257	G;C;A	257;258;257	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2887	191.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1529	1531	ATC	255;254;256	A,G;T,G,C;C	254,1;252,1,1;256	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2887	191.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1541	1543	GTG	262;265;261	G,T;T;G	261,1;265;261	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2887	191.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1541	1543	GTG	262;265;261	G,T;T;G	261,1;265;261	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2887	191.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2045	2047	ACC	248;249;250	A;C,G;C,G	248;248,1;249,1	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2887	191.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2099	2101	GCG	249;248;250	G;C,G;G	249;247,1;250	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2887	191.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2099	2101	GCG	249;248;250	G;C,G;G	249;247,1;250	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2887	191.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2222	2224	GGC	250;248;247	G;G,C;C	250;247,1;247	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2887	191.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2231	2233	GGC	259;260;262	G;G;C	259;260;262	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4440	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2887	191.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2249	2251	CCG	269;266;267	C,G;C,A;G	267,2;265,1;267	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6260	ponA	2397	2397	99.21	ponA.l15.c4.ctg.1	3613	216.2	0	.	p	.	0	F13V	NONSYN	37	39	TTT	698	700	GTT	311;312;310	G;T,C;T	311;311,1;310	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6260	ponA	2397	2397	99.21	ponA.l15.c4.ctg.1	3613	216.2	0	.	p	.	0	R257Q	NONSYN	769	771	CGG	1430	1432	CAG	276;277;273	C;A,G;G	276;276,1;273	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6260	ponA	2397	2397	99.21	ponA.l15.c4.ctg.1	3613	216.2	0	.	p	.	0	R272Q	NONSYN	814	816	CGG	1475	1477	CAG	256;257;256	C;A;G	256;257;256	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6260	ponA	2397	2397	99.21	ponA.l15.c4.ctg.1	3613	216.2	0	.	p	.	0	T295A	NONSYN	883	885	ACC	1544	1546	GCT	299;301;301	G;C;T,C,G	299;301;299,1,1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	539	6260	ponA	2397	2397	99.21	ponA.l15.c4.ctg.1	3613	216.2	0	.	p	.	0	A300V	NONSYN	898	900	GCG	1559	1561	GTG	298;300;298	G;T;G,C	298;300;297,1	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2820	porA	1146	1146	99.83	porA.l6.c4.ctg.1	2334	150.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	849	849	C	219	C	219	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3382	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1763	235.7	0	.	p	.	0	E48G	NONSYN	142	144	GAA	594	596	GGA	315;318;316	G;G,T;A	315;317,1;316	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3382	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1763	235.7	0	.	p	.	0	F135L	NONSYN	403	405	TTT	855	857	CTT	303;301;304	C;T,C;T	303;300,1;304	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3382	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1763	235.7	0	.	p	.	0	R143G	NONSYN	427	429	AGA	879	881	GGA	302;302;301	G;G;A	302;302;301	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3382	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1763	235.7	0	.	p	.	0	D171G	NONSYN	511	513	GAT	963	965	GGT	298;297;297	G;G;T	298;297;297	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3382	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1763	235.7	0	.	p	.	0	G189S	NONSYN	565	567	GGC	1017	1019	AGC	299;302;303	A;G,C;C,T	299;301,1;301,2	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3382	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1763	235.7	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1083	1083	T	294	T	294	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3382	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1763	235.7	1	SNP	p	G120K	0	.	.	358	360	GGT	810	812	GGT	301;301;298	G;G;T,G,C	301;301;296,1,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3382	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1763	235.7	1	SNP	p	A121D	0	.	.	361	363	GCC	813	815	GCC	297;301;307	G,T;C,T;C	296,1;300,1;307	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3382	porB1b	1035	1035	95.82	porB1b.l15.c17.ctg.1	1763	235.7	1	SNP	p	A121N	0	.	.	361	363	GCC	813	815	GCC	297;301;307	G,T;C,T;C	296,1;300,1;307	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11870	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	5390	275.0	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2241	2243	AAT	292;292;288	A,G;A,T;T	291,1;291,1;288	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1738	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1567	138.5	1	SNP	p	V57M	1	.	.	169	171	ATG	780	782	ATG	325;328;326	A,G;T;G,A	324,1;328;325,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
